Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Suzanne M. Hanlon currently holds 80,693 shares of Zynerba Pharmaceuticals, Inc. (ZYNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Suzanne M. Hanlon has been a net buyer of ZYNE stock. They have purchased $75.8K and sold $31.6K worth of shares.
Suzanne M. Hanlon's most recent insider trade was on Jan 21, 2021, when they sold 37,000 shares at $0.00 per share.
Suzanne M. Hanlon serves as Executive at Zynerba Pharmaceuticals, Inc. (ZYNE). They have executed 4 insider transactions totaling $107.4K over their tenure at the company.
Suzanne M. Hanlon holds the position of Executive at Zynerba Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Suzanne M. Hanlon has shown a buying trading pattern, with $75.8K in total purchases and $31.6K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Suzanne M. Hanlon was on Aug 5, 2015, when they purchased $53.8K worth of ZYNE shares. This transaction involved 3,000 shares at $17.92 per share.
Suzanne M. Hanlon currently owns 80,693 shares of Zynerba Pharmaceuticals, Inc. (ZYNE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Suzanne M. Hanlon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Suzanne M. Hanlon has 4 Form 4 filings on record as an insider at Zynerba Pharmaceuticals, Inc..
Set alerts for Suzanne M. Hanlon and 40,000+ other insiders.